1 Sampson AP, "Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast" 55 (55): S28-S31, 2000
2 Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma, "This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986" 136 : 225-244, 1987
3 Kim HB, "The leukotriene C4 synthase (A-444C) promoter polymorphism is associated with the severity of exercise-induced asthma in Korean children" 117 : 1191-1192, 2006
4 Hao L, "The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma" 36 : 735-741, 2006
5 Acevedo N, "The A-444C polymorphism of leukotriene C4 synthase gene is associated with IgE antibodies to Dermatophagoides pteronyssinus in a Colombian population" 119 : 505-507, 2007
6 Lee SY, "Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA)" 37 : 1487-1493, 2007
7 Joseph-Bowen J, "Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood" 114 : 1040-1045, 2004
8 Sayers I, "Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population" 33 : 1103-1110, 2003
9 Cowburn AS, "Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma" 101 : 834-846, 1998
10 Bigby TD, "Molecular cloning of the human leukotriene C4 synthase gene and assignment to chromosome 5q35" 2 : 637-646, 1996
1 Sampson AP, "Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast" 55 (55): S28-S31, 2000
2 Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma, "This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986" 136 : 225-244, 1987
3 Kim HB, "The leukotriene C4 synthase (A-444C) promoter polymorphism is associated with the severity of exercise-induced asthma in Korean children" 117 : 1191-1192, 2006
4 Hao L, "The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma" 36 : 735-741, 2006
5 Acevedo N, "The A-444C polymorphism of leukotriene C4 synthase gene is associated with IgE antibodies to Dermatophagoides pteronyssinus in a Colombian population" 119 : 505-507, 2007
6 Lee SY, "Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA)" 37 : 1487-1493, 2007
7 Joseph-Bowen J, "Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood" 114 : 1040-1045, 2004
8 Sayers I, "Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population" 33 : 1103-1110, 2003
9 Cowburn AS, "Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma" 101 : 834-846, 1998
10 Bigby TD, "Molecular cloning of the human leukotriene C4 synthase gene and assignment to chromosome 5q35" 2 : 637-646, 1996
11 Choi JH, "Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase" 114 : 337-344, 2004
12 Sanak M, "Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma" 350 : 1599-1600, 1997
13 Asano K, "Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma" 12 : 565-570, 2002
14 Garcia-Martin E, "Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms" 9 : 487-497, 2008
15 Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999" 161 : 309-329, 2000
16 Zhang J, "Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis" 17 : 242-249, 2006
17 Crowther SD, "Current treatment of asthma--focus on leukotrienes" 1 : 1021-1040, 2000
18 Kedda MA, "Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma" 113 : 889-895, 2004
19 Lynch KR, "Characterization of the human cysteinyl leukotriene CysLT1 receptor" 399 : 789-793, 1999
20 Sanz C, "Analysis of 927T> C CYSLTRI and -444A > C LTC4S polymorphisms in patients with asthma" 16 : 331-337, 2006
21 Sayers I, "Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma" 58 : 417-424, 2003
22 Arriba-Mendez S, "927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis" 17 : 323-328, 2006
23 Van Sambeek R, "5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States" 106 : 72-76, 2000